The role of limited life expectancy in personalized treatment decisions: one in six patients aged 80+ years with a basal cell carcinoma die within 2 years of diagnosis in England
Year: 2025
Type: article
Study design: Observational Study
Abstract: This study examines the survival outcomes of elderly patients (aged 80+ years) diagnosed with BCC in England, revealing that nearly half die within 5 years of diagnosis. The findings highlight the potential overtreatment in this population, emphasizing the need for incorporating frailty and life expectancy assessments into personalized treatment decisions to avoid unnecessary surgical risks.
Source: British Journal of Dermatology
DOI: 10.1093/bjd/ljaf135
Authors: Opeoluwa Fariyike, Nicholas A Johnson, Birgitta van Bodegraven, Kate Quirke, Zoe C Venables, James Powell
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,920
OpenAlex ID: W4409442313